ArticleCase reports in hematology2024

High-Risk Chronic Lymphocytic Leukemia Complicating the Course of Imatinib-Treated Chronic Myeloid Leukemia: Successful Disease Management With Dual Tyrosine Kinase Inhibition.

Daniel James et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.